Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Accumulated Expenses (2016 - 2025)

Chemours (CC) has 12 years of Accumulated Expenses data on record, last reported at $33.0 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 91.67% year-over-year to $33.0 million; the TTM value through Dec 2025 reached $33.0 million, down 91.67%, while the annual FY2025 figure was $33.0 million, 91.67% down from the prior year.
  • Accumulated Expenses reached $33.0 million in Q4 2025 per CC's latest filing, down from $580.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.1 billion in Q4 2023 and bottomed at $17.0 million in Q4 2021.
  • Average Accumulated Expenses over 5 years is $337.3 million, with a median of $134.5 million recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: soared 6129.41% in 2023, then plummeted 95.52% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $17.0 million in 2021, then changed by 0.0% to $17.0 million in 2022, then skyrocketed by 6129.41% to $1.1 billion in 2023, then tumbled by 62.61% to $396.0 million in 2024, then tumbled by 91.67% to $33.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $33.0 million in Q4 2025, $580.0 million in Q3 2025, and $585.0 million in Q2 2025.